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220 Interaction of temperature with hematocrit level and pH determines safe
duration of hypothermic circulatory arrest
Takahiko Sakamoto, MD, David Zurakowski, PhD, Lennart F. Duebener, MD, Hart G. W.
Lidov, MD, Gregory L. Holmes, MD, Richard J. Hurley, DVM, Peter C. Laussen, MD, and
Richard A. Jonas, MD, Boston, Mass
A laboratory study using 76 piglets demonstrated that hematocrit level and pH as well as
temperature determine safe duration of hypothermic circulatory arrest.
233 Total aortic arch replacement with a branched graft and limited circulatory
arrest of the brain
Nicholas T. Kouchoukos, MD, and Paolo Masetti, MD, St Louis, Mo
A technique for total aortic arch replacement with a branched graft, antegrade brain perfusion
without the need for direct cannulation of the brachiocephalic arteries or a separate perfusion
circuit, and a brief (13 minutes) period of circulatory arrest of the brain is presented.
238 Does off-pump total arterial grafting increase the incidence of intraoperative
graft failure?
Lognathen Balacumaraswami, FRCS, Yasir Abu-Omar, MRCS, Kyriakos Anastasiadis, MD,
Bikram Choudhary, MBBS, David Pigott, FRCA, Siu-Kae Yeong, and David P. Taggart, MD,
PhD, FRCS, Oxford, United Kingdom, and Ottawa, Ontario, Canada
Intraoperative fluorescence imaging is a useful method for verifying graft patency and allows
immediate correction of graft failure. This prospective study demonstrated a low but otherwise
unsuspected incidence (1.5%) of graft failure. There was no difference in graft failure rates
between on-pump and off-pump total arterial grafting.
245 Angiogenic growth factors and/or cellular therapy for myocardial
regeneration: A comparative study
Juan C. Chachques, MD, PhD, Fabricio Duarte, MD, Barbara Cattadori, MD, Abdel Shafy,
MD, Nermine Lila, DVM, PhD, Gilles Chatellier, MD, Jean-Noel Fabiani, MD, and Alain F.
Carpentier, MD, PhD, Paris, France
The goal of this study was to compare the effects of myoblast implantation and the injection of
VEGF in a model of myocardial infarct in large animals. Results showed that myogenic cell
transplantation, associated or not with angiogenic growth factors, improves regional myocardial
contractility and limits LV chamber remodeling. In contrast, no functional benefit was
demonstrated in the group treated with growth factors alone. Angiogenesis was observed only
in animals treated with VEGF alone. These results suggest that angiogenic growth factors may
be delivered into myocardial infarct areas several days before cell transplantation to first
improve local perfusion conditions for cell survival (preconditioning).
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